Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...
Vicarious Surgical (NYSE: RBOT) (the "Company"), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the successful completion of an ...
"The prognosis was so poor that the hospital called in grief counsellors to speak with my family and help prepare them." ...
A recent study published in the Frontiers in Pediatrics revealed that among children with suspected appendicitis, a positive ...
Interim data from 14 patients with progressive lung cancers in dose-escalation cohorts of systemically administered Olvi-Vec-primed immunochemotherapy across ongoing SCLC and NSCLC trials; enrollment ...
Gastrointestinal (GI) Cancers Symposium, Dani Castillo, MD, medical oncologist, City of Hope, shared new research titled, “Impact of metastatic sites and Lauren subtype on survival outcomes of ...
Unlike conventional procedures that require large incisions, minimally invasive surgeries are performed through tiny openings ...
Genelux (GNLX) announced interim results from two ongoing trials – Phase 1b/2 SCLC and Phase 2 VIRO-25 – evaluating systemic administration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback